LIVER DISEASES
![Foto de LIVER DISEASES](/img/grupo.png)
![Foto de University Hospital Heidelberg](/img/noimage_org.png)
University Hospital Heidelberg
Heidelberg, AlemaniaPublications in collaboration with researchers from University Hospital Heidelberg (7)
2024
2023
-
Criteria for preclinical models of cholangiocarcinoma: scientific and medical relevance
Nature Reviews Gastroenterology and Hepatology, Vol. 20, Núm. 7, pp. 462-480
-
Liquid biopsy-based protein biomarkers for risk prediction, early diagnosis, and prognostication of cholangiocarcinoma
Journal of Hepatology, Vol. 79, Núm. 1, pp. 93-108
2022
-
Bcl-xL as prognostic marker and potential therapeutic target in cholangiocarcinoma
Liver International, Vol. 42, Núm. 12, pp. 2855-2870
2020
-
miRNA profiling of biliary intraepithelial neoplasia reveals stepwise tumorigenesis in distal cholangiocarcinoma via the miR-451a/ATF2 axis
Journal of Pathology, Vol. 252, Núm. 3, pp. 239-251
2019
-
Nuclear Translocation of RELB Is Increased in Diseased Human Liver and Promotes Ductular Reaction and Biliary Fibrosis in Mice
Gastroenterology, Vol. 156, Núm. 4, pp. 1190-1205.e14
-
RIPK1 and death receptor signaling drive biliary damage and early liver tumorigenesis in mice with chronic hepatobiliary injury
Cell Death and Differentiation, Vol. 26, Núm. 12, pp. 2710-2726